DK0728006T3 - Anvendelse af mannosephosphater til behandlingen af fibrotiske lidelser - Google Patents

Anvendelse af mannosephosphater til behandlingen af fibrotiske lidelser

Info

Publication number: DK0728006T3
Authority: DK; Denmark
Prior art keywords: pct; treatment; mannose; fibrotic disorders; phosphates
Prior art date: 1992-03-17

Application number

DK93906680T

Other languages

Danish (da)

English (en)

Inventor

Mark William James Ferguson

Original Assignee

Btg Int Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-03-17

Filing date

1993-03-16

Publication date

2000-10-30

1993-03-16 Application filed by Btg Int Ltd filed Critical Btg Int Ltd

2000-10-30 Application granted granted Critical

2000-10-30 Publication of DK0728006T3 publication Critical patent/DK0728006T3/da

Links

229910019142 PO4 Inorganic materials 0.000 title abstract 3
230000003176 fibrotic effect Effects 0.000 title abstract 2
-1 mannose phosphates Chemical class 0.000 title 1
235000021317 phosphate Nutrition 0.000 title 1
NDVRKEKNSBMTAX-MVNLRXSJSA-N (2s,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O NDVRKEKNSBMTAX-MVNLRXSJSA-N 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000010452 phosphate Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
230000036573 scar formation Effects 0.000 abstract 1
230000029663 wound healing Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)

DK93906680T 1992-03-17 1993-03-16 Anvendelse af mannosephosphater til behandlingen af fibrotiske lidelser DK0728006T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB929205800A GB9205800D0 (en)	1992-03-17	1992-03-17	Treatment of fibrotic disorders
PCT/GB1993/000541 WO1993018777A1 (en)	1992-03-17	1993-03-16	Use of mannose phosphates for the treatment of fibrotic disorders

Publications (1)

Publication Number	Publication Date
DK0728006T3 true DK0728006T3 (da)	2000-10-30

Family

ID=10712310

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93906680T DK0728006T3 (da)	1992-03-17	1993-03-16	Anvendelse af mannosephosphater til behandlingen af fibrotiske lidelser

Country Status (18)

Country	Link
US (1)	US5520926A (pt)
EP (1)	EP0728006B1 (pt)
JP (1)	JP3930556B2 (pt)
AT (1)	ATE196847T1 (pt)
AU (1)	AU667887B2 (pt)
CA (1)	CA2130805C (pt)
DE (1)	DE69329559T2 (pt)
DK (1)	DK0728006T3 (pt)
ES (1)	ES2151903T3 (pt)
GB (2)	GB9205800D0 (pt)
GR (1)	GR3035117T3 (pt)
IL (1)	IL105079A (pt)
NO (1)	NO306808B1 (pt)
NZ (1)	NZ249915A (pt)
PT (1)	PT728006E (pt)
SG (1)	SG49899A1 (pt)
WO (1)	WO1993018777A1 (pt)
ZA (1)	ZA931869B (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9106678D0 (en) *	1991-03-28	1991-05-15	Ferguson Mark W J	Wound healing
SE9403137D0 (sv) *	1994-09-20	1994-09-20	Perstorp Ab	Derivatives of carbohydrates and compositions containing them
US6566339B1 (en)	1995-08-04	2003-05-20	Renovo Limited	Pharmaceutical composition
GB9516012D0 (en) *	1995-08-04	1995-10-04	Univ Manchester	Pharmaceutical composition
GB2306481A (en) *	1995-10-21	1997-05-07	Univ Manchester	Pharmaceutical comprising a stimulator of activin and/or inhibin
US6093388A (en) *	1996-08-12	2000-07-25	Btg International Limited	Mannose-6-phosphate composition and its use in treating fibrotic disorders
GB9616896D0 (en) *	1996-08-12	1996-09-25	British Tech Group	Pharmaceutical compositions
DE19758059C2 (de) *	1997-12-29	2001-10-04	Thorsten Marquardt	Verwendung von Mannose zur Bekämpfung der Proteinverlust-Enteropathie
WO2002030432A1 (en) *	2000-06-23	2002-04-18	Cambridgemed, Inc	Agent for reduction of scar formation by using wound alkalinization
EP1345602B1 (en) *	2000-11-30	2010-07-21	Novodermix International Limited	Wound healing
US20030031689A1 (en) *	2001-08-09	2003-02-13	Thomas Mammone	Method of skin exfoliation
US6822033B2 (en)	2001-11-19	2004-11-23	United States Gypsum Company	Compositions and methods for treating set gypsum
AU2003209308A1 (en) *	2002-01-22	2003-09-02	Genzyme Corporation	Use of tgf-beta antagonists to treat or to prevent chronic transplant rejection
EP1507543A4 (en) *	2002-05-09	2006-07-26	Cambridgemed Inc	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF WOOD WITH BLOOD PLASMA OR SERUM
GB0217136D0 (en)	2002-07-24	2002-09-04	Renovo Ltd	Wound healing & treatment of fibrosis
KR100492913B1 (ko) *	2002-08-23	2005-06-03	주식회사 태평양	피부 감작 및 자극을 완화하는 피부 외용제 조성물
US20050136126A1 (en) *	2003-03-17	2005-06-23	Cambridgemed, Inc.	Agent for reduction of scar formation by using wound alkalinization
JP4634027B2 (ja) *	2003-05-16	2011-02-16	花王株式会社	ビタミンｄ様活性代替用剤
US7276486B2 (en) *	2004-03-15	2007-10-02	Kimberly-Clark Worldwide, Inc.	Compositions for vaginal treatment
EP1740615B1 (en)	2004-03-31	2014-11-05	Genentech, Inc.	Humanized anti-tgf-beta antibodies
WO2006044433A2 (en) *	2004-10-13	2006-04-27	The Ohio State University Research Foundation	Methods to treat or prevent viral-associated lymphoproliferative disorders
US7323184B2 (en) *	2005-08-22	2008-01-29	Healagenics, Inc.	Compositions and methods for the treatment of wounds and the reduction of scar formation
US20070048391A1 (en) *	2005-08-23	2007-03-01	Cambridgemed, Inc.	Composition for reduction of scar formation on wound scar
EP2862867A3 (en)	2005-10-25	2015-08-05	The Johns Hopkins University	Methods and compositions for the treatment of Marfan syndrome and associated disorders
US8454952B2 (en)	2006-03-13	2013-06-04	The Johns Hopkins University	Augmentation of endothelial thromboresistance
MX2009003518A (es)	2006-10-03	2009-08-25	Genzyme Corp	Uso de antagonistas de tgf-beta para tratar a los infantes en riesgo de desarrollar displasia brocopulmonar.
US8070895B2 (en)	2007-02-12	2011-12-06	United States Gypsum Company	Water resistant cementitious article and method for preparing same
US8329308B2 (en)	2009-03-31	2012-12-11	United States Gypsum Company	Cementitious article and method for preparing the same
GB0910078D0 (en)	2009-06-11	2009-07-22	Renovo Ltd	Uses of mannose-6-phosphate
GB0916333D0 (en)	2009-09-17	2009-10-28	Renovo Ltd	Improvement of tendon repair
GB0916334D0 (en) *	2009-09-17	2009-10-28	Renovo Ltd	Inhibition of tendon adhesions
SI2835053T1 (sl)	2010-03-12	2016-09-30	Genzyme Corporation	Kombinirana terapija za zdravljenje raka dojke
US20140170236A1 (en) *	2010-11-05	2014-06-19	Priscilla Hayes Petty	Use of phosphoric acid
CN103429732B (zh)	2010-12-27	2015-09-16	Lsip基金运营联合公司	iPS细胞及其制造方法
US20140308275A1 (en)	2011-07-27	2014-10-16	Inserm (Institut National De La Sante Et De La Recherche Medicale	Methods for diagnosing and treating myhre syndrome
AU2011379972B2 (en)	2011-10-26	2016-05-12	Seattle Children's Research Institute	Cysteamine in the treatment of fibrotic disease
ES2897740T3 (es)	2011-12-28	2022-03-02	Kyoto Prefectural Public Univ Corp	Normalización del cultivo de células endoteliales de la córnea
CA2927898C (en)	2013-10-31	2021-11-16	Kyoto Prefectural Public University Corporation	Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endothelium
WO2016187312A1 (en)	2015-05-18	2016-11-24	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Methods and compositions for treating an alphavirus infection
US20250186652A1 (en) *	2022-03-08	2025-06-12	University Of Mississippi Medical Center	Articles and methods for improved tissue healing
CN115260256A (zh) *	2022-07-22	2022-11-01	河南中医药大学	一种甘露糖磷酸化衍生物及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE756953A (fr) *	1969-10-02	1971-04-01	Merck & Co Inc	Potentialisation d'antibiotiques
JPS5631156B2 (pt) *	1973-09-25	1981-07-20
IT1170618B (it) *	1981-01-13	1987-06-03	Foscama Biomed Chim Farma	Preparato farmacologico di frutto sio-1,6-difosfato ad azione terapeutica nei pazienti ustionati
US4703040A (en) *	1985-04-03	1987-10-27	Markov Angel K	Treatment of adult respiratory distress syndrome (ARDS) using fructose diphosphate (FDP)
US4889844A (en) *	1985-10-22	1989-12-26	Silvetti Sr Anthony N	Fructose containing wound healing preparation
ATE78166T1 (de) *	1985-10-22	1992-08-15	Silvetti Anthony N	Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
AU607690B2 (en) *	1985-12-24	1991-03-14	Marion Laboratories, Inc.	Use of synthetic sulfated saccharides to enhance wound healing
JPS62243675A (ja) *	1986-04-15	1987-10-24	Kao Corp	ｐＨ緩衝法
EP0429522B1 (en) *	1988-08-19	1996-06-26	The Australian National University	Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
GB8917414D0 (en) *	1989-07-29	1989-09-13	Translift Material Handling	Narrow aisle lift truck
FI921353A0 (fi) *	1989-09-29	1992-03-27	Jolla Cancer Res Found	Inhibering av transformerande vaextfaktor b foer foerhindrande av ackumulation av extracellulaer matris.
SE8904354D0 (sv) *	1989-12-21	1989-12-21	Matti Siren	A pharmaceutical composition
GB9106678D0 (en) *	1991-03-28	1991-05-15	Ferguson Mark W J	Wound healing
JPH0558868A (ja) *	1991-08-27	1993-03-09	Kao Corp	親水性紫外線吸収剤及びこれを含有する化粧料
WO1993019783A1 (en) *	1992-04-01	1993-10-14	The Whittier Institute For Diabetes And Endocrinology	Methods of inhibiting or enhancing scar formation in the cns
JPH09155319A (ja) *	1995-12-13	1997-06-17	Takeo Tsutsui	重金属含有焼却灰等、シュレッダーダストの無公害化処理方法および再利用材の製造方法

1992
- 1992-03-17 GB GB929205800A patent/GB9205800D0/en active Pending
1993
- 1993-03-16 US US08/290,939 patent/US5520926A/en not_active Expired - Lifetime
- 1993-03-16 SG SG1996008660A patent/SG49899A1/en unknown
- 1993-03-16 WO PCT/GB1993/000541 patent/WO1993018777A1/en not_active Ceased
- 1993-03-16 CA CA002130805A patent/CA2130805C/en not_active Expired - Lifetime
- 1993-03-16 AT AT93906680T patent/ATE196847T1/de active
- 1993-03-16 EP EP93906680A patent/EP0728006B1/en not_active Expired - Lifetime
- 1993-03-16 PT PT93906680T patent/PT728006E/pt unknown
- 1993-03-16 GB GB9305344A patent/GB2265310B/en not_active Expired - Lifetime
- 1993-03-16 ES ES93906680T patent/ES2151903T3/es not_active Expired - Lifetime
- 1993-03-16 AU AU37590/93A patent/AU667887B2/en not_active Expired
- 1993-03-16 IL IL105079A patent/IL105079A/en not_active IP Right Cessation
- 1993-03-16 JP JP51635793A patent/JP3930556B2/ja not_active Expired - Lifetime
- 1993-03-16 DE DE69329559T patent/DE69329559T2/de not_active Expired - Lifetime
- 1993-03-16 DK DK93906680T patent/DK0728006T3/da active
- 1993-03-16 NZ NZ249915A patent/NZ249915A/en not_active IP Right Cessation
- 1993-03-16 ZA ZA931869A patent/ZA931869B/xx unknown
1994
- 1994-09-16 NO NO943451A patent/NO306808B1/no not_active IP Right Cessation
2000
- 2000-12-19 GR GR20000402805T patent/GR3035117T3/el unknown

Also Published As

Publication number	Publication date
GR3035117T3 (en)	2001-03-30
GB9205800D0 (en)	1992-04-29
DE69329559T2 (de)	2001-05-31
CA2130805A1 (en)	1993-09-30
JP3930556B2 (ja)	2007-06-13
ATE196847T1 (de)	2000-10-15
NO306808B1 (no)	1999-12-27
SG49899A1 (en)	1998-06-15
CA2130805C (en)	2003-06-24
IL105079A0 (en)	1993-07-08
IL105079A (en)	1998-06-15
EP0728006A1 (en)	1996-08-28
AU3759093A (en)	1993-10-21
NO943451L (no)	1994-09-16
ZA931869B (en)	1994-09-16
ES2151903T3 (es)	2001-01-16
AU667887B2 (en)	1996-04-18
GB2265310A (en)	1993-09-29
JPH07504909A (ja)	1995-06-01
NZ249915A (en)	1996-08-27
EP0728006B1 (en)	2000-10-11
WO1993018777A1 (en)	1993-09-30
US5520926A (en)	1996-05-28
GB2265310B (en)	1996-09-25
DE69329559D1 (de)	2000-11-16
PT728006E (pt)	2001-04-30
NO943451D0 (no)	1994-09-16
GB9305344D0 (en)	1993-05-05

Publication	Publication Date	Title
DK0728006T3 (da)	2000-10-30	Anvendelse af mannosephosphater til behandlingen af fibrotiske lidelser
NO307027B1 (no)	2000-01-31	Anvendelse av riluzol ved behandling av neurologiske lesjoner relatert til traumatiske skader
KR960701051A (ko)	1996-02-24	이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
DE69733132D1 (de)	2005-06-02	Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
BG104599A (en)	2001-03-30	Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
AU5144396A (en)	1996-10-02	Trisubstituted phenyl derivatives
DE69526937D1 (de)	2002-07-11	Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
DE69738981D1 (de)	2008-10-23	Gereinigte zubereitungen von 10-propargyl-10-deazaaminopterin und verfahren zu ihrer verwendung in der tumorbehandlung
TW238305B (pt)	1995-01-11
DK1291018T3 (da)	2005-09-12	Phosphonatananaloger til mannose-6phosphat og deres anvendelse i behandlingen af sår og fibrotiske lidelser
EP0744176A3 (en)	2002-05-15	Methods for inhibiting bone loss
DE69626816D1 (de)	2003-04-24	Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
PT841937E (pt)	2004-11-30	Utilizacao de betaglicano para reduzir a formacao de cicatrizes
DE69906701D1 (de)	2003-05-15	Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATA57894A (de)	2000-09-15	Mittel zur behandlung von osteoporose
DK1133297T3 (da)	2003-11-24	Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin
BG102009A (en)	1998-11-30	Method for the treatment of manic and two-pole disease